iVIGA lomiʻi ʻi he fale ngaohiʻanga koloa
These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan
Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 June. The technology gains life-saving medical insights by analysing human excrement. Kuo faile ʻe he kautaha ha ngaahi teniti ʻe tolu ʻoku ne ʻufiʻufi ʻa e ngaahi ʻelemeniti ʻo hono falemaloloo fakafaitoʻo sensor resistance.
Three Toilets Detection Health Technologies
The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, ʻIulope, Siapani mo Siaina.
A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, ʻE lava ke ʻiloʻi ʻe he tekinolosia ʻo e ngaahi meʻa fakatekinolosia ʻa e tupuʻanga ʻo e toto ʻi he tohitufa gastrointestinal.
A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.
Fakatatau ki he OutSense, Yfat Scialom, who predicts that “mo e fakaʻauha ʻo e faitoʻo fakaʻilekitulonika, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, laukovi ki mahaki mo urinary tohitufa.
Its solution consists of a multispectral optical sensor, ha maʻuʻanga maama mo ha meʻangaue sivi autonomous ʻoku kau ai ha fehokotakiʻanga WiFi. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.
OutSense has developed tools to diagnose abnormalities in human excreta. Fakamatala naʻe maʻu mei he toto naʻe maʻú, fakataha mo ha ngaahi fakamatala fakaikiiki kehe ʻo e taimi mei he fanoa ʻa e toto ki he excretion, ʻomi ha fakaikiiki ʻo e toto pathology. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.
At the beginning of June, OutSense announced that CommuniCare, a large healthcare company with more than 90 healthcare facilities in the US, will begin piloting its technology this year. In addition to this pilot, OutSense also plans to conduct clinical trials in Israel and Japan.
Visit More News at Viga.cc News